{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T10:34:05Z","timestamp":1776767645766,"version":"3.51.2"},"reference-count":52,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T00:00:00Z","timestamp":1655078400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004396","name":"Thailand Research Fund","doi-asserted-by":"publisher","award":["RTA6280004"],"award-info":[{"award-number":["RTA6280004"]}],"id":[{"id":"10.13039\/501100004396","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ratchadapisek Sompoch Endowment Fund, Chulalongkorn University","award":["DNS 64_007_30_002_1"],"award-info":[{"award-number":["DNS 64_007_30_002_1"]}]},{"name":"Ratchadaphiseksomphot Matching Fund, Faculty of Medicine, Chulalongkorn University","award":["RA-MF-22\/64"],"award-info":[{"award-number":["RA-MF-22\/64"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Significant liver fibrosis regression occurs after hepatitis C virus (HCV) therapy. However, the impact of direct-acting antivirals (DAAs) on steatosis is less clear. This study was aimed at evaluating serial fibrosis and steatosis alterations in patients with HCV genotype 1, who achieved sustained virological response (SVR). We enrolled 55 HCV mono-infected and 28 HCV\/HIV co-infected patients receiving elbasvir\/grazoprevir from a clinical trial. Fibrosis and steatosis were assessed at baseline, follow-up week-24 (FUw24) and week-72 (FUw72) by magnetic resonance elastography (MRE) and proton density fat fraction (PDFF), respectively. Patatin-like phospholipase domain-containing protein 3 (<jats:italic>PNPLA3<\/jats:italic>) rs738409, transmembrane six superfamily member 2 (<jats:italic>TM6SF2<\/jats:italic>) rs58542926 and membrane bound O-acyltransferase domain-containing 7 (<jats:italic>MBOAT7<\/jats:italic>) rs641738 polymorphisms were determined by allelic discrimination. Overall, mean MRE decreased significantly from baseline to FUw24 and FUw72. At FUw72, patients with baseline F2-F4 had higher rate of \u226530% MRE decline compared with individuals with baseline F0-F1 (30.2%vs.3.3%,<jats:italic>P<\/jats:italic>= 0.004). In multivariate analysis, significant fibrosis was associated with MRE reduction. The prevalence of steatosis (PDFF\u22655.2%) at baseline was 21.7%. Compared to baseline, there were 17 (20.5%) patients with decreased PDFF values at FUw72 (&lt;30%), while 23 (27.7%) patients had increased PDFF values (\u226530%). Regarding the overall cohort, mean PDFF significantly increased from baseline to FUw72, and displayed positive correlation with body mass index (BMI) alteration. In multivariate analysis, the presence of diabetes,<jats:italic>PNPLA3<\/jats:italic>CG+GG genotypes and increased BMI at FUw72 were significantly associated with progressive steatosis after SVR. Other genetic variants were not related to fibrosis and steatosis alteration. This study concluded that HCV eradication was associated with fibrosis improvement. However, progressive steatosis was observed in a proportion of patients, particularly among individuals with metabolic derangement and<jats:italic>PNPLA3<\/jats:italic>variants. The combined clinical parameters and host genetic factors might allow a better individualized strategy in this sub-group of patients to alleviate progressive steatosis after HCV cure.<\/jats:p>","DOI":"10.1371\/journal.pone.0269641","type":"journal-article","created":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T17:34:11Z","timestamp":1655141651000},"page":"e0269641","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":16,"title":["Improvement of liver fibrosis, but not steatosis, after HCV eradication as assessment by MR-based imaging: Role of metabolic derangement and host genetic variants"],"prefix":"10.1371","volume":"17","author":[{"given":"Natthaya","family":"Chuaypen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surachate","family":"Siripongsakun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pantajaree","family":"Hiranrat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natthaporn","family":"Tanpowpong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anchalee","family":"Avihingsanon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2926-8671","authenticated-orcid":true,"given":"Pisit","family":"Tangkijvanich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2022,6,13]]},"reference":[{"issue":"10207","key":"pone.0269641.ref001","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0140-6736(19)32320-7","article-title":"Hepatitis C","volume":"394","author":"CW Spearman","year":"2019","journal-title":"Lancet"},{"issue":"9","key":"pone.0269641.ref002","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nrgastro.2013.107","article-title":"Epidemiology and natural history of HCV infection","volume":"10","author":"B Hajarizadeh","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"7","key":"pone.0269641.ref003","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S1473-3099(15)00485-5","article-title":"Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis","volume":"16","author":"L Platt","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"pone.0269641.ref004","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/nrgastro.2016.176","article-title":"Global epidemiology and burden of HCV infection and HCV-related disease","volume":"14","author":"AP Thrift","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"pone.0269641.ref005","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1053\/j.gastro.2018.10.033","article-title":"What Are the Benefits of a Sustained Virologic Response to Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection?","volume":"156","author":"GN Ioannou","year":"2019","journal-title":"Gastroenterology"},{"key":"pone.0269641.ref006","article-title":"Efficacy of elbasvir\/grazoprevir therapy in HCV genotype-1 with or without HIV infection: role of HCV core antigen monitoring and improvement of liver stiffness and steatosis","author":"M Chayanupatkul","year":"2020","journal-title":"Antiviral therapy"},{"issue":"7","key":"pone.0269641.ref007","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1056\/NEJM200102153440706","article-title":"Liver biopsy","volume":"344","author":"AA Bravo","year":"2001","journal-title":"N Engl J Med"},{"issue":"1","key":"pone.0269641.ref008","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1053\/j.gastro.2015.11.016","article-title":"Time to Replace Assessment of Liver Histology With MR-Based Imaging Tests to Assess Efficacy of Interventions for Nonalcoholic Fatty Liver Disease","volume":"150","author":"CD Byrne","year":"2016","journal-title":"Gastroenterology"},{"issue":"8","key":"pone.0269641.ref009","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1007\/s00261-017-1211-7","article-title":"Evaluation of hepatic fibrosis: a review from the society of abdominal radiology disease focus panel","volume":"42","author":"JM Horowitz","year":"2017","journal-title":"Abdom Radiol (NY)"},{"issue":"7","key":"pone.0269641.ref010","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1007\/s00330-019-06072-4","article-title":"Diagnostic value of MRI-PDFF for hepatic steatosis in patients with non-alcoholic fatty liver disease: a meta-analysis","volume":"29","author":"J Gu","year":"2019","journal-title":"Eur Radiol"},{"issue":"3","key":"pone.0269641.ref011","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1053\/j.gastro.2016.10.026","article-title":"Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease","volume":"152","author":"CC Park","year":"2017","journal-title":"Gastroenterology"},{"issue":"7","key":"pone.0269641.ref012","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1111\/apt.14554","article-title":"Viral eradication reduces both liver stiffness and steatosis in patients with chronic hepatitis C virus infection who received direct-acting anti-viral therapy","volume":"47","author":"T Tada","year":"2018","journal-title":"Alimentary pharmacology & therapeutics"},{"issue":"1","key":"pone.0269641.ref013","doi-asserted-by":"crossref","first-page":"7845","DOI":"10.1038\/s41598-018-26293-9","article-title":"Eradication of hepatitis C virus is associated with the attenuation of steatosis as evaluated using a controlled attenuation parameter","volume":"8","author":"K Shimizu","year":"2018","journal-title":"Sci Rep"},{"issue":"5","key":"pone.0269641.ref014","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/MEG.0000000000001106","article-title":"Changes in liver stiffness and steatosis among patients with hepatitis C virus infection who received direct-acting antiviral therapy and achieved sustained virological response","volume":"30","author":"N Kobayashi","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"11","key":"pone.0269641.ref015","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.3748\/wjg.v24.i11.1269","article-title":"Fatty liver in hepatitis C patients post-sustained virological response with direct-acting antivirals","volume":"24","author":"M Noureddin","year":"2018","journal-title":"World J Gastroenterol"},{"issue":"2","key":"pone.0269641.ref016","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/jmv.24950","article-title":"Serial changes in liver stiffness and controlled attenuation parameter following direct-acting antiviral therapy against hepatitis C virus genotype 1b","volume":"90","author":"N Ogasawara","year":"2018","journal-title":"Journal of medical virology"},{"issue":"2","key":"pone.0269641.ref017","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jceh.2018.06.009","article-title":"Therapy with Oral Directly Acting Agents in Hepatitis C Infection Is Associated with Reduction in Fibrosis and Increase in Hepatic Steatosis on Transient Elastography","volume":"9","author":"G Rout","year":"2019","journal-title":"J Clin Exp Hepatol."},{"key":"pone.0269641.ref018","article-title":"Metabolic comorbidities and male sex influence steatosis in chronic hepatitis C after viral eradication by direct-acting antiviral therapy (DAAs): Evaluation by the controlled attenuation parameter (CAP)","author":"A C espiati","year":"2020","journal-title":"Dig Liver Dis"},{"issue":"5","key":"pone.0269641.ref019","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/apt.15976","article-title":"Association between steatohepatitis biomarkers and hepatocellular carcinoma after hepatitis C elimination","volume":"52","author":"E Ogawa","year":"2020","journal-title":"Alimentary pharmacology & therapeutics"},{"issue":"5","key":"pone.0269641.ref020","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/jvh.12871","article-title":"Host genetic factors associated with hepatocellular carcinoma in patients with hepatitis C virus infection: A systematic review","volume":"25","author":"AJ Walker","year":"2018","journal-title":"Journal of viral hepatitis"},{"issue":"12","key":"pone.0269641.ref021","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1111\/apt.15738","article-title":"Review article: the emerging role of genetics in precision medicine for patients with non-alcoholic steatohepatitis","volume":"51","author":"B Carlsson","year":"2020","journal-title":"Alimentary pharmacology & therapeutics"},{"issue":"9","key":"pone.0269641.ref022","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1111\/jgh.12613","article-title":"Advanced liver fibrosis by transient elastography, fibrosis 4, and alanine aminotransferase\/platelet ratio index among Asian hepatitis C with and without human immunodeficiency virus infection: role of vitamin D levels","volume":"29","author":"A Avihingsanon","year":"2014","journal-title":"J Gastroenterol Hepatol"},{"issue":"5","key":"pone.0269641.ref023","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00535-018-01533-x","article-title":"Independent and additive effects of PNPLA3 and TM6SF2 polymorphisms on the development of non-B, non-C hepatocellular carcinoma","volume":"54","author":"M Raksayot","year":"2019","journal-title":"J Gastroenterol"},{"issue":"3","key":"pone.0269641.ref024","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1148\/radiol.2016160209","article-title":"Liver Stiffness Measurements with MR Elastography: Agreement and Repeatability across Imaging Systems, Field Strengths, and Pulse Sequences","volume":"281","author":"AT Trout","year":"2016","journal-title":"Radiology"},{"issue":"3","key":"pone.0269641.ref025","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1148\/radiol.2373041639","article-title":"Hepatic fat fraction: MR imaging for quantitative measurement and display\u2014early experience","volume":"237","author":"HK Hussain","year":"2005","journal-title":"Radiology"},{"issue":"4","key":"pone.0269641.ref026","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2463\/mrms.11.291","article-title":"Magnetic resonance elastography for staging liver fibrosis in chronic hepatitis C","volume":"11","author":"S Ichikawa","year":"2012","journal-title":"Magn Reson Med Sci"},{"issue":"3","key":"pone.0269641.ref027","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1053\/j.gastro.2015.11.048","article-title":"Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography","volume":"150","author":"K Imajo","year":"2016","journal-title":"Gastroenterology"},{"issue":"1","key":"pone.0269641.ref028","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1186\/s13063-018-2989-5","article-title":"Statistical analysis plan of a randomized controlled trial to compare a restrictive strategy to usual care for the effectiveness of cholecystectomy (SECURE trial).","volume":"19","author":"SZ Wennmacker","year":"2018","journal-title":"Trials"},{"key":"pone.0269641.ref029","doi-asserted-by":"crossref","first-page":"666182","DOI":"10.3389\/fpsyg.2021.666182","article-title":"Report Quality of Generalized Linear Mixed Models in Psychology: A Systematic Review","volume":"12","author":"R Bono","year":"2021","journal-title":"Front Psychol."},{"key":"pone.0269641.ref030","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3389\/fgene.2017.00167","article-title":"Departure from Hardy Weinberg Equilibrium and Genotyping Error","volume":"8","author":"B Chen","year":"2017","journal-title":"Front Genet."},{"issue":"3","key":"pone.0269641.ref031","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.cgh.2014.09.046","article-title":"Diagnostic performance of magnetic resonance elastography in staging liver fibrosis: a systematic review and meta-analysis of individual participant data","volume":"13","author":"S Singh","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"pone.0269641.ref032","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1002\/hep.26455","article-title":"Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials","volume":"58","author":"M Noureddin","year":"2013","journal-title":"Hepatology (Baltimore, Md."},{"issue":"9","key":"pone.0269641.ref033","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S2468-1253(20)30186-2","article-title":"Novel antisense inhibition of diacylglycerol O-acyltransferase 2 for treatment of non-alcoholic fatty liver disease: a multicentre, double-blind, randomised, placebo-controlled phase 2 trial.","volume":"5","author":"R Loomba","year":"2020","journal-title":"Lancet Gastroenterol Hepatol."},{"issue":"5","key":"pone.0269641.ref034","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1136\/gutjnl-2021-324264","article-title":"Clinical utility of 30% relative decline in MRI-PDFF in predicting fibrosis regression in non-alcoholic fatty liver disease","volume":"71","author":"N Tamaki","year":"2022","journal-title":"Gut"},{"issue":"1","key":"pone.0269641.ref035","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jhep.2018.09.024","article-title":"Longitudinal correlations between MRE, MRI-PDFF, and liver histology in patients with non-alcoholic steatohepatitis: Analysis of data from a phase II trial of selonsertib","volume":"70","author":"S Jayakumar","year":"2019","journal-title":"J Hepatol"},{"issue":"6","key":"pone.0269641.ref036","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1002\/jmv.26490","article-title":"Changes of liver stiffness measured by magnetic resonance elastography during direct-acting antivirals treatment in patients with chronic hepatitis C","volume":"93","author":"M Higuchi","year":"2021","journal-title":"Journal of medical virology"},{"issue":"5","key":"pone.0269641.ref037","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1007\/s00261-020-02860-5","article-title":"Liver cT1 decreases following direct-acting antiviral therapy in patients with chronic hepatitis C virus.","volume":"46","author":"ANA Jayaswal","year":"2021","journal-title":"Abdom Radiol (NY)"},{"issue":"5","key":"pone.0269641.ref038","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1053\/j.gastro.2020.09.065","article-title":"Fibrosis Regression After Eradication of Hepatitis C Virus: From Bench to Bedside","volume":"160","author":"DC Rockey","year":"2021","journal-title":"Gastroenterology"},{"issue":"5","key":"pone.0269641.ref039","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1053\/jhep.2002.36370","article-title":"Hepatitis C virus genotype 3 is cytopathic to hepatocytes: Reversal of hepatic steatosis after sustained therapeutic response","volume":"36","author":"D Kumar","year":"2002","journal-title":"Hepatology (Baltimore, Md."},{"issue":"1","key":"pone.0269641.ref040","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0168-8278(00)80166-X","article-title":"Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3","volume":"33","author":"L Rubbia-Brandt","year":"2000","journal-title":"J Hepatol"},{"issue":"9","key":"pone.0269641.ref041","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1111\/j.1572-0241.2003.07640.x","article-title":"Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome","volume":"98","author":"AJ Sanyal","year":"2003","journal-title":"The American journal of gastroenterology"},{"issue":"4","key":"pone.0269641.ref042","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jhep.2017.06.003","article-title":"New trends on obesity and NAFLD in Asia","volume":"67","author":"JG Fan","year":"2017","journal-title":"J Hepatol"},{"issue":"7","key":"pone.0269641.ref043","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1007\/s11606-020-05782-6","article-title":"Excess Weight Gain After Cure of Hepatitis C Infection with Direct-Acting Antivirals","volume":"35","author":"A Do","year":"2020","journal-title":"J Gen Intern Med"},{"issue":"10","key":"pone.0269641.ref044","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9101495","article-title":"Weight Gain after Interferon-Free Treatment of Chronic Hepatitis C-Results from the German Hepatitis C-Registry (DHC-R)","volume":"9","author":"B Schlevogt","year":"2021","journal-title":"Biomedicines"},{"issue":"12","key":"pone.0269641.ref045","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","article-title":"Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease","volume":"40","author":"S Romeo","year":"2008","journal-title":"Nat Genet"},{"issue":"3","key":"pone.0269641.ref046","first-page":"456","article-title":"PNPLA3 rs738409 Polymorphism Associated with Hepatic Steatosis and Advanced Fibrosis in Patients with Chronic Hepatitis C Virus","volume":"10","author":"JH Fan","year":"2016","journal-title":"A Meta-Analysis. Gut Liver"},{"issue":"10","key":"pone.0269641.ref047","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1111\/apt.16346","article-title":"MAFLD considerations as a part of the global hepatitis C elimination effort: an international perspective","volume":"53","author":"Y Fouad","year":"2021","journal-title":"Alimentary pharmacology & therapeutics"},{"issue":"12","key":"pone.0269641.ref048","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1007\/s00535-020-01731-6","article-title":"PNPLA3 and HLA-DQB1 polymorphisms are associated with hepatocellular carcinoma after hepatitis C virus eradication","volume":"55","author":"D Miki","year":"2020","journal-title":"J Gastroenterol"},{"issue":"6","key":"pone.0269641.ref049","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1002\/hep.31500","article-title":"Hepatic Fat-Genetic Risk Score Predicts Hepatocellular Carcinoma in Patients With Cirrhotic HCV Treated With DAAs","volume":"72","author":"E Degasperi","year":"2020","journal-title":"Hepatology (Baltimore, Md."},{"issue":"6","key":"pone.0269641.ref050","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1002\/hep.26767","article-title":"Association between the PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma: Evidence from a meta-analysis of individual participant data","volume":"59","author":"E Trepo","year":"2014","journal-title":"Hepatology (Baltimore, Md."},{"issue":"2","key":"pone.0269641.ref051","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.cgh.2020.10.018","article-title":"Expert Panel Review on Nonalcoholic Fatty Liver Disease in Persons With Human Immunodeficiency Virus","volume":"20","author":"JE Lake","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"pone.0269641.ref052","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1002\/hep.31639","article-title":"Stratification of Residual Risk of HCC Following HCV Clearance With Direct-Acting Antivirals in Patients With Advanced Fibrosis and Cirrhosis","volume":"72","author":"VW Setiawan","year":"2020","journal-title":"Hepatology (Baltimore, Md."}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0269641","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T02:09:48Z","timestamp":1700705388000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0269641"}},"subtitle":[],"editor":[{"given":"Jee-Fu","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,6,13]]},"references-count":52,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,6,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0269641","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,13]]}}}